Detalles de la búsqueda
1.
Prevalence of resistance-associated substitutions and retreatment of patients failing a glecaprevir/pibrentasvir regimen.
J Antimicrob Chemother
; 75(11): 3349-3358, 2020 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32772078
2.
Efficacy and Freedom: Patient Experiences with the Transition from Daily Oral to Long-Acting Injectable Antiretroviral Therapy to Treat HIV in the Context of Phase 3 Trials.
AIDS Behav
; 24(12): 3473-3481, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32410051
3.
Increasing importance of European lineages in seeding the hepatitis C virus subtype 1a epidemic in Spain.
Euro Surveill
; 24(9)2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30862327
4.
Daily tenofovir disoproxil fumarate/emtricitabine and hydroxychloroquine for pre-exposure prophylaxis of COVID-19: a double-blind placebo-controlled randomized trial in healthcare workers.
Clin Microbiol Infect
; 29(1): 85-93, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35940567
5.
The efficacy and safety of maraviroc addition to a stable antiretroviral regimen in subjects with suppressed plasma HIV-RNA is not influenced by age.
AIDS Res Hum Retroviruses
; 31(9): 893-7, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26059859
6.
Safety, efficacy and indications of prescription of maraviroc in clinical practice: Factors associated with clinical outcomes.
Antiviral Res
; 120: 79-84, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25977241
Resultados
1 -
6
de 6
1
Próxima >
>>